In this segment, the panel turned its attention to Duchenne muscular dystrophy (DMD), which affects just one in every 3500 male births according to moderator Abhimanyu Garg, MD. That equates to 20,000 new cases every year.
Please feel free to access some of our latest articles on DMD below:
Early Diagnosis and Treatment – The Use of Ataluren in the Effective Management of Duchenne Muscular Dystrophy
Eugenio Mercuri, Ros Quinlivan, Sylvie Tuffery-Giraud
European Neurological Review. 2018;13(1):31–7. DOI: https://doi.org/10.17925/ENR.2018.13.1.31
Advances in Pulmonary Care in Duchenne Muscular Dystrophy
Oscar H Mayer, Erik K Henricson, Craig M McDonald, Gunnar M Buyse
US Neurology, 2017;13(1):35–41. DOI: https://doi.org/10.17925/USN.2017.13.01.35
Corticosteroids in Duchenne Muscular Dystrophy—A Deflazacort Review
Jordan S Dubow, James M Meyer
US Neurology, 2016;12(1):12–6. DOI: http://doi.org/10.17925/USN.2016.12.01.12
Idebenone as a Novel Therapeutic Approach for Duchenne Muscular Dystrophy
Gunnar M Buyse, Nuri Gueven, Craig M McDonald
European Neurological Review, 2015;10(2):189–94. DOI: http://doi.org/10.17925/ENR.2015.10.02.189
New Perspectives on the Diagnosis and Management of Duchenne Muscular Dystrophy
Francesco Muntoni, Annemieke Aartsma-Rus, Eugenio Mercuri, Hanns Lochmüller
European Neurological Review, 2015;10(1):73–8. DOI: http://doi.org/10.17925/ENR.2015.10.01.73
